Skip to content
Open in App
Illumina logo

Illumina

web2

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis...

Symbol · I1LM34
Company profile

About

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem; and strategic collaboration with Integrated DNA Technologies to enable a DRAGEN, secondary analysis pipeline for IDT xGena, FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels, delivering an integrated, end-to-end solution for somatic oncology research. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

People

Company team

SG

Scott Gottlieb

Independent Chairman

Company leadership profile.

CD

Caroline D. Dorsa

Independent Director

Company leadership profile.

AS

Anna S. Richo

Independent Director

Company leadership profile.

JT

Jacob Thaysen

CEO & Director

Company leadership profile.

SE

Susan E. Siegel

Independent Director

Company leadership profile.

SB

Scott B. Ullem

Independent Director

Company leadership profile.

PW

Philip W. Schiller

Independent Director

Company leadership profile.

LG

Leslie G. Biesecker

Member of Ethics Advisory Board

Company leadership profile.

FC

Freda C. Lewis-Hall

Member of Ethics Advisory Board

Company leadership profile.

NF

Nita Farahany

Member of Ethics Advisory Board

Company leadership profile.

KA

Keith Arlyn Meister

Independent Director

Company leadership profile.

DP

David P. King

Independent Director

Company leadership profile.

DM

Daniel M. Skovronsky

Independent Director

Company leadership profile.

Expert coverage

1 expert evaluated Illumina.

Orbitrum research

Experts evaluating Illumina

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment